Three-year antipsychotic effectiveness in the outpatient care of schizophrenia: observational versus randomized studies resultsJosep Maria Haro
San Joan de Déu Serveis de Salut Mental, Fundació Sant Joan de Déu, Dr Antoni Pujades, 42, 08830 Sant Boi de Llobregat, Barcelona, Spain
Eur Neuropsychopharmacol 17:235-44. 2007
..Antipsychotic maintenance in SOHO was higher than the results of previous randomized studies...
Health status of the advanced elderly in six European countries: results from a representative survey using EQ-5D and SF-12Hans Helmut Konig
Department of Medical Sociology and Health Economics, University Medical Center Hamburg Eppendorf, Martinistrasse 52, Hamburg, Germany
Health Qual Life Outcomes 8:143. 2010
..Due to demographic change, the advanced elderly represent the fastest growing population group in Europe. Health problems tend to be frequent and increasing with age within this cohort...
The 12-item World Health Organization Disability Assessment Schedule II (WHO-DAS II): a nonparametric item response analysisJuan V Luciano
Parc Sanitari Sant Joan de Deu, Fundació Sant Joan de Déu, Sant Boi de Llobregat, Barcelona, Spain
BMC Med Res Methodol 10:45. 2010
..We also explored differential item functioning (DIF) in men and women...
Cross-national clinical and functional remission rates: Worldwide Schizophrenia Outpatient Health Outcomes (W-SOHO) studyJosep Maria Haro
Parc Sanitari Sant Joan de Deu, Fundació Sant Joan de Déu, CIBERSAM, Dr Antoni Pujadas, 42, 08830 Sant Boi de Llobregat, Barcelona, Spain
Br J Psychiatry 199:194-201. 2011
..Evidence suggests that schizophrenia may have a better outcome for individuals living in low- and middle-income countries compared with affluent settings...
The SOHO (Schizophrenia Outpatient Health Outcome) study: implications for the treatment of schizophreniaJosep Maria Haro
Sant Joan de Deu SSM, Fundació Sant Joan de Déu, Sant Boi de Llobregat, Barcelona, Spain
CNS Drugs 20:293-301. 2006
..This important information is likely to impact on the future use of antipsychotics and will assist clinicians in refining the use of these drugs and improving the outcome of patients to whom they are prescribed...
Methodological aspects in the assessment of treatment effects in observational health outcomes studiesJosep Maria Haro
Research and Development Unit, RIRAG Network FIS G03 061, Sant Joan de Deu SSM, Fundació Sant Joan de Déu, Sant Boi, Barcelona, Spain
Appl Health Econ Health Policy 5:11-25. 2006
..Observational studies, when properly conducted and when using adequate statistical methods, can provide valid information on the evaluation of health technologies...
Predictors of switching from mania to depression in a large observational study across Europe (EMBLEM)Eduard Vieta
Department of Psychiatry, Hospital Clinic, University of Barcelona IDIBAPS, CIBER SAM, Barcelona, Spain
J Affect Disord 118:118-23. 2009
..Large observational studies may be useful in identifying variables that predict switch to depression after mania and provide data on medication use and outcomes in "real world" patients...
Impact of mental disorders and chronic physical conditions in health-related quality of life among primary care patients: results from an epidemiological studyAlejandra Pinto-Meza
Sant Joan de Deu SSM, Fundació Sant Joan de Déu, Barcelona, Spain
Qual Life Res 18:1011-8. 2009
..To estimate the comorbidity of mental disorders with chronic physical conditions and to assess their independent and combined effects on health-related quality of life (HRQOL)...
Gender differences in response to antipsychotic treatment in outpatients with schizophreniaJudith Usall
Sant Joan de Déu Serveis de Salut Mental, Fundació Sant Joan de Déu, Sant Boi de Llobregat, Barcelona, Spain
Psychiatry Res 153:225-31. 2007
..In conclusion, in this group of outpatients with schizophrenia, gender is a predictor of clinical response to antipsychotic treatment, but its influence is not the same for all antipsychotics...
Why do clinicians maintain antidepressants in some patients with acute mania? Hints from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM), a large naturalistic studyAdriane R Rosa
Bipolar Disorders Program, Hospital Clinic, University of Barcelona, CIBERSAM, Barcelona, Spain
J Clin Psychiatry 71:1000-6. 2010
..Antidepressants are supposed to be withdrawn during a manic episode. The aim of this study was to analyze the characteristics of manic patients who received antidepressants during a manic phase in a large, naturalistic study...
Antipsychotic treatment discontinuation in previously untreated patients with schizophrenia: 36-month results from the SOHO studyJosep Maria Haro
Sant Joan de Deu SSM, Fundació Sant Joan de Déu, CIBER Salud Mental Instituto de Salud Carlos III, Sant Boi de Llobregat, Barcelona, Spain
J Psychiatr Res 43:265-73. 2009
..In conclusion, treatment effectiveness and tolerability varied among antipsychotic medications in previously untreated patients with schizophrenia. The results should be interpreted conservatively given the observational study design...
Suicide ideation across reproductive life cycle of women. Results from a European epidemiological studyJudith Usall
Sant Joan de Deu SSM, Fundació Sant Joan de Déu, Instituto de Salud Carlos III, Centro de Investigación en Red de Salud Mental CIBERSAM, Spain
J Affect Disord 116:144-7. 2009
..The aim of the present study is to compare suicide ideation among women in the pre-, peri-, and post-menopause using a cross-sectional household survey of non-institutionalised adults from six European countries...
Burden of chronic physical conditions and mental disorders in primary careAnna Fernandez
Sant Joan de Deu SSM, Fundació Sant Joan de Déu, Research and Development Unit, Dr Antoni Pujadas, 42, 08830 Sant Boi de Llobregat, Barcelona, Spain
Br J Psychiatry 196:302-9. 2010
..The World Health Organization (WHO) has stated that the three leading causes of burden of disease in 2030 are projected to include HIV/AIDS, unipolar depression and ischaemic heart disease...
Remission and relapse in the outpatient care of schizophrenia: three-year results from the Schizophrenia Outpatient Health Outcomes studyJosep Maria Haro
Sant Joan de Deu SSM, Fundació Sant Joan de Déu, Sant Boi de Llobregat, Barcelona, Spain
J Clin Psychopharmacol 26:571-8. 2006
..The results should be interpreted conservatively because of the observational, nonrandomized study design...
What is the relative importance of self reported psychotic symptoms in epidemiological studies? Results from the ESEMeD--Catalonia StudySusana Ochoa
Sant Joan de Déu Serveis de Salut Mental, Fundació Sant Joan de Déu, Dr Pujades, 42, Sant Boi de Llobregat, Barcelona, CIBERSAM Spain
Schizophr Res 102:261-9. 2008
....
Adequacy of antidepressant treatment in Spanish primary care: a naturalistic six-month follow-up studyAlejandra Pinto-Meza
Department of Research and Development, Sant Joan de Deu SSM, Carrer Dr Antoni Pujades, 42 Sant Boi de Llobregat, Barcelona, Spain
Psychiatr Serv 59:78-83. 2008
..Factors that could be associated with adequacy of care also were explored...
Gender differences in outcomes of acute mania: a 12-month follow-up studyLaia Miquel
Sant Joan de Deu SSM, Fundació Sant Joan de Déu, Centro de Investigación Biomédica en Red de Salud Mental, Catalonia, Spain
Arch Womens Ment Health 14:107-13. 2011
..Women had a faster time to mania improvement and a higher risk of developing a depressive episode during the 12-month follow-up period...
Obsessive-compulsive symptom dimensions in the general population: results from an epidemiological study in six European countriesM A Fullana
Anxiety Unit, IAPS, Hospital del Mar and Department of Psychiatry, Autonomous University of Barcelona, Barcelona, Spain
J Affect Disord 124:291-9. 2010
..The prevalence of obsessive-compulsive symptom dimensions and their sociodemographic and psychopathological correlates at the population level are unknown...
Do needs, symptoms or disability of outpatients with schizophrenia influence family burden?Susana Ochoa
Unitat de Recerca i Desenvolupament de Sant Joan de Déu SSM Research Unit CIBER SAM, C Pujades, 42, 08330, Sant Boi de Llobregat, Barcelona, Spain
Soc Psychiatry Psychiatr Epidemiol 43:612-8. 2008
..This could cause high levels of family burden. The objective of this study is to assess the relationship between the patients' needs and other clinical and disability variables and the level of family burden...
Marginal structural models might overcome confounding when analyzing multiple treatment effects in observational studiesDavid Suarez
Research and Development Unit, Sant Joan de Deu SSM, Fundació Sant Joan de Déu, RETICS RD06 0011 REM TAP Network, Sant Boi, Barcelona, Spain
J Clin Epidemiol 61:525-30. 2008
..Until now, MSMs have not been used to compare the effects of more than two treatments...
Overview of the findings from the European SOHO studyDavid Suarez
Sant Joan de Déu Serveis de Salut Mental, Fundació Sant Joan de Déu, Barcelona, Spain
Expert Rev Neurother 8:873-80. 2008
..The results from the SOHO study indicate that differences in effectiveness and tolerability do exist between the antipsychotics...
Adaptation and validation of the quality-of-life scale: Satisfaction with Life Domains Scale by Baker and IntagliataJanina Carlson
Research and Developmental Unit of Sant Joan de Déu SSM, Fundació Sant Joan de Déu, 08330 Sant Boi de Llobregat, Barcelona, Spain
Compr Psychiatry 50:76-80. 2009
..There are few quality-of-life instruments specifically for schizophrenia; thus, the objective of our study is to adapt and validate the Satisfaction with Life Domains Scale (SLDS) by Baker and Intagliata...
Fluoxetine and imipramine: are there differences in cost-utility for depression in primary care?Antoni Serrano-Blanco
Sant Joan de Déu Serveis de Salut Mental, Fundació Sant Joan de Déu, Sant Boi de Ll, Barcelona, Spain
J Eval Clin Pract 15:195-203. 2009
..Previous cost-utility studies, comparing selective serotonin reuptake inhibitors and tricyclic antidepressants, have used modelling techniques or have not included indirect costs in the economic analyses...
Olanzapine monotherapy and olanzapine combination therapy in the treatment of mania: 12-week results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) observational studyEduard Vieta
Bipolar Disorders Program, Hospital Clinic, University of Barcelona IDIBAPS, Barcelona, Spain
J Affect Disord 106:63-72. 2008
....
[Prevalence and physical-mental comorbidity of chronic back and neck pain in Spain: results from the ESEMeD Study]Alejandra Pinto-Meza
, , Sant Boi de Llobregat, Barcelona,
Med Clin (Barc) 127:325-30. 2006
..CONCLUSIONS: CBP-CNP is highly prevalent and comorbid with other physical and mental conditions. Comorbidity negatively affects individuals global functioning...
Neurocognitive performance and negative symptoms: are they equal in explaining disability in schizophrenia outpatients?Victoria Villalta-Gil
Research and Development Unit, , , C/ Dr. Antoni Pujadas 42, 08830, St. Boi de Llobregat, Barcelona, Spain
Schizophr Res 87:246-53. 2006
..The present findings suggest that further investigation on the mediators between clinical and social outcomes may help to design specific treatments to reduce disability...
Antipsychotic type and correlates of antipsychotic treatment discontinuation in the outpatient treatment of schizophreniaJosep Maria Haro
Research and Development Unit, Sant Joan de Déu Serveis de Salut Mental, Dr Antoni Pujades 42, 08030 Sant Boi, Barcelona, Spain
Eur Psychiatry 21:41-7. 2006
..The findings from this study should be interpreted conservatively because of its non-randomized observational design...
Treatment adequacy of anxiety and depressive disorders: primary versus specialised care in SpainAnna Fernandez
Sant Joan de Deu SSM, Fundació Sant Joan de Déu, Sant Boi de Llobregat, Barcelona, Spain
J Affect Disord 96:9-20. 2006
..This study aimed to describe the adequacy of treatment for Anxiety and Depressive disorders in Spain, how this differs between providers (primary versus specialised care) and which factors are associated with appropriate care...
Gender differences in response to antidepressant treatment prescribed in primary care. Does menopause make a difference?Alejandra Pinto-Meza
Sant Joan de Deu SSM, Fundació Sant Joan de Déu, Spain
J Affect Disord 93:53-60. 2006
....
Psychotropic prescribing in Catalonia: results from an epidemiological studyMaria Rubio-Valera
Research and Development Unit, Parc Sanitari Sant Joan de Deu, Fundació Sant Joan de Déu, Sant Boi de Llobregat, Barcelona, Spain
Fam Pract 29:154-62. 2012
..Prescription of PSD is associated with clinical and non-clinical factors. Purpose. To describe the patterns of PSD prescribing over a 12-month period and to determine the factors associated with this in a PC population...
The transcription factor SP4 is reduced in postmortem cerebellum of bipolar disorder subjects: control by depolarization and lithiumRaquel Pinacho
Parc Sanitari Sant Joan de Deu, Fundació Sant Joan de Déu, Centro de Investigación Biomédica en Red de Salud Mental CIBERSAM, Barcelona, Spain
Bipolar Disord 13:474-85. 2011
..We hypothesized that SP4 levels may be altered in the brain of bipolar disorder (BD) subjects and regulated by neuronal activity and drug treatment...
Treatment-seeking behavior of erectile dysfunction patients in Europe: Results of the Erectile Dysfunction Observational StudyJosep Maria Haro
Fundació Sant Joan de Déu, Esplugues de Llobregat, Spain
J Sex Med 3:530-40. 2006
....
Use of concomitant medication with antipsychotic treatment in outpatients with schizophrenia: results from the European Schizophrenia Outpatients Health Outcomes (SOHO) studyDiego Novick
Eli Lilly and Company, Windlesham, Surrey, UK
Prog Neuropsychopharmacol Biol Psychiatry 29:972-82. 2005
..The results should be interpreted conservatively due to the observational design of SOHO...
Symptomatic remission in previously untreated patients with schizophrenia: 2-year results from the SOHO studyDiego Novick
Eli Lilly and Company, Lilly Research Centre, Erl Wood Manor, Sunninghill Road, Windlesham, Surrey, GU20 6PH, UK
Psychopharmacology (Berl) 191:1015-22. 2007
..Symptomatic remission is an achievable goal of treatment in patients with schizophrenia...
Cost-utility analysis of treatment with olanzapine compared with other antipsychotic treatments in patients with schizophrenia in the pan-European SOHO studyMartin Knapp
Centre for the Economics of Mental Health, Institute of Psychiatry, London, UK
Pharmacoeconomics 26:341-58. 2008
..To determine the cost utility of treating schizophrenic patients with olanzapine compared with other antipsychotics in a naturalistic outpatient setting...
Open-label olanzapine treatment in bipolar I disorder: clinical and work functional outcomesLizheng Shi
Department of Health Systems Management, Tulane University, New Orleans, LA, USA
Curr Med Res Opin 22:961-6. 2006
..The objective of this study was to describe clinical and work functional outcomes associated with 6-month open-label olanzapine treatment for bipolar I disorder...
Methodological approach for assessing the cost-effectiveness of treatments using longitudinal observational data: the SOHO studyFrank Windmeijer
Department of Economics, University of Bristol, UK
Int J Technol Assess Health Care 22:460-8. 2006
....
[Prevalence and risk factors for suicide ideation, plans and attempts in the Spanish general population. Results from the ESEMeD study]Andrea Gabilondo
Unidad de Investigación en Servicios Sanitarios, Institut Municipal d Investigacio Medica, Barcelona, Espana
Med Clin (Barc) 129:494-500. 2007
..Suicide is a public health problem and it is increasing in Spain. The objective of this study is to analyze the prevalence and risk factors of suicide related outcomes (ideation, plan and attempt) using data from the ESEMeD-Spain project...
Meso-level comparison of mental health service availability and use in Chile and SpainLuis Salvador-Carulla
Psicost Scientific Association, San Marcos 6, Jerez, Cadiz 11403 Spain
Psychiatr Serv 59:421-8. 2008
..The purpose of this study was to describe mental health care in catchment health areas in Chile and Spain in order to complement information reported at the macro-level (countries or regions)...
Stability and treatment outcome of distinct classes of maniaInge van Rossum
Medical Department, Eli Lilly Nederland, Grootslag 1 5, Houten, The Netherlands
Eur Psychiatry 23:360-7. 2008
..Differential treatment course and outcome after 12 weeks of treatment were examined for three distinct classes of patients with acute mania in bipolar disorder...
Assessment of remission in schizophrenia with the CGI and CGI-SCH scalesJosep Maria Haro
Acta Psychiatr Scand 117:156. 2008
Clinical factors influencing the prescription of antidepressants and benzodiazepines: results from the European study of the epidemiology of mental disorders (ESEMeD)Koen Demyttenaere
Department of Psychiatry, University Hospital Gasthuisberg, Leuven, Belgium
J Affect Disord 110:84-93. 2008
..To examine factors associated with the use of antidepressants (AD) and benzodiazepines (BZD) in 6 European countries...
Clinical consequences of switching antipsychotic drugs in outpatients with schizophrenia: 36-month results from the European Schizophrenia Outpatient Health Outcomes studyDiego Novick
Eli Lilly and Company, Windlesham, Surrey, UK
Int Clin Psychopharmacol 23:203-8. 2008
..Patients who switched to olanzapine experienced a higher weight gain. In conclusion, among patients switching antipsychotic medication, those who switched to olanzapine had better long-term outcomes...
Differences in lifetime use of services for mental health problems in six European countriesViviane Kovess-Masfety
Mutuelle Générale de l Education Nationale MGEN Foundation for Public Health, EA 4069, University of Paris 5, Paris, France
Psychiatr Serv 58:213-20. 2007
....
Sexual intercourse frequency in men presenting for treatment of erectile dysfunction: results from the pan-European erectile dysfunction observational studyAlan Riley
Lancashire School of Health and Postgraduate Medicine, University of Central Lancashire, Preston, United Kingdom
J Sex Marital Ther 33:3-18. 2007
....
Pharmacological treatment and other predictors of treatment outcomes in previously untreated patients with schizophrenia: results from the European Schizophrenia Outpatient Health Outcomes (SOHO) studyIsabelle Gasquet
INSERM U669, Maison des Adolescents, Hopital Cochin, AP HP, Paris, France
Int Clin Psychopharmacol 20:199-205. 2005
..The results should be interpreted conservatively due to the observational study design...
Cross-national prevalence and risk factors for suicidal ideation, plans and attemptsMatthew K Nock
Department of Psychology, Harvard University, Cambridge, Massachusetts 02138, USA
Br J Psychiatry 192:98-105. 2008
..Suicide is a leading cause of death worldwide; however, the prevalence and risk factors for the immediate precursors to suicide - suicidal ideation, plans and attempts - are not wellknown, especially in low- and middle-income countries...